EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 26-Oct-2026 01:15 ET (26-Oct-2026 05:15 GMT/UTC)

6-Jul-2026

Tumor-on-a-chip reveals how pancreatic cancer hijacks immune cells

University of Miami Miller School of Medicine
Peer-Reviewed Publication

A new tumor-on-a-chip model lets Sylvester researchers watch how pancreatic cancer co-opts immune cells in real time, revealing how tumors build defenses that resist treatment. The findings point to possible ways to disrupt those signals and make resistant tumors more vulnerable to therapy.

Journal: Biofabrication

6-Jul-2026

Ochsner MD Anderson earns national accreditation and recognition for excellence in cancer care

Ochsner Health System
Business Announcement

Together, these recognitions illustrate Ochsner MD Anderson’s focus on delivering coordinated comprehensive cancer care from prevention and screening to diagnosis, treatment and survivorship. Ochsner MD Anderson’s multidisciplinary approach brings together specialists across cancer disciplines to support patients with complex and varied needs.

6-Jul-2026

Dana-Farber research supports FDA approval of new therapy for “double-positive” metastatic breast cancer

Dana-Farber Cancer Institute
Business Announcement

The U.S. Food and Drug Administration (FDA) has approved a new therapy regimen for patients with “double-positive” metastatic breast cancer based on results of the phase 3 PATINA study led by Otto Metzger, MD, Associate Medical Director of International Strategic Initiatives at Dana-Farber Cancer Institute. The PATINA trial demonstrated that the addition of the CDK 4/6 inhibitor palbociclib to standard therapy in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer resulted in a more than 15-month improvement in progression-free survival. The findings were reported in the New England Journal of Medicine and also presented at the San Antonio Breast Cancer Symposium in December 2024.

6-Jul-2026

Rare benign kidney tumor case highlights value of biopsy and minimally invasive treatment

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – July 6, 2026 – A new case report was published in Volume 17 of Oncotarget on July 2, 2026, titled “Renal oncocytoma: Α case report and literature review.”

Journal: Oncotarget

6-Jul-2026

Men may be more likely than women to receive later-stage diagnoses for many cancer types in the United States

American Association for Cancer Research
Peer-Reviewed Publication

Between 2015 and 2022, men were more likely than women to be diagnosed with regional and/or distant stages of 20 nonreproductive solid cancer types in the United States, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR).

6-Jul-2026

Molecular nanostructures can be activated using ultrasound

Heinrich-Heine University Duesseldorf
Peer-Reviewed Publication

Researchers from Heinrich Heine University Düsseldorf (HHU) have taken an important step toward developing intelligent molecular materials. The team headed by Dr Bernd M. Schmidt (Institute of Organic Chemistry and Macromolecular Chemistry) and Professor Dr Jan Meisner (Institute of Physical Chemistry) has shown that complex molecular nanostructures can be selectively activated, disassembled in a controlled way and even reassembled again using ultrasound. The results have now been published in the renowned scientific journal Nature Communications. These findings could, for example, aid the development of more targeted cancer medication in the future.

Journal: Nature Communications

6-Jul-2026

Mass producing engineered T cells for cancer therapy using Platinum TALEN

Hiroshima University
Peer-Reviewed Publication

Hiroshima University researchers have demonstrated a proof of concept for the mass-production of genome-edited T cells that can be used to treat malignant tumors, using a genetic engineering technique called Platinum TALEN.

Journal: Cytotherapy
Funder: Japan Agency for Medical Research and Development, Ministry of Education, Culture, Sports, Science, and Technology of Japan

6-Jul-2026

Researchers develop AI test to predict recurrence of breast cancer

New York University
Peer-Reviewed Publication

A team of researchers reports the creation of an AI test that predicts the risk of breast cancer recurrence—one that does so more quickly and more inexpensively than current methods, which involve genomic testing.

Journal: Nature Communications

6-Jul-2026

New brush test detects oral cancer in one hour

Queen Mary University of London
Peer-Reviewed Publication

A paper published in the Nature journal Biomarker Research by a cross-University team led by Queen Mary University of London researchers, validates the use of a non-invasive brush biopsy test that can detect oral cancer within one hour. This inexpensive test could revolutionise oral cancer detection, and prevent unnecessary (painful) scalpel biopsies.

Journal: Biomarker Research

6-Jul-2026

Novel biomarker research offers new hope in the fight against colorectal cancer

University of Sharjah
Peer-Reviewed Publication

New research offers fresh hope to patients with colorectal cancer, as advances in liquid biomarker technologies are poised to reshape detection, diagnosis and treatment of the disease.

Journal: Clinica Chimica Acta